Bayer Innovation announces licensing agreement with greenovation Biotech
In this context, glycosylation is a process by which certain sugar molecules are added to proteins in plants. Understanding and controlling this process in plants can enable researchers to enhance considerably the activity or bioavailability of new proteins produced by plants which can be used for therapeutic purposes.
"Collaboration with greenovation will give us access to innovative glycosylation technology. This will complement our own skills and technologies and has particular applicability to our work on plant-made pharmaceuticals," explained Gerd Seidl, Global Project Leader for this field at Bayer Innovation GmbH.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.